Pre-trabeculectomy intravitreal injections of Bevacizumab for treating neovascular glaucoma in diabetic patients

Pre-trabeculectomy intravitreal injections of Bevacizumab for treating neovascular glaucoma in diabetic patients

Background/Aim. Neovascular glaucoma (NVG) is a secondary glaucoma caused by occlusion of the trabecular network of newly formed blood vessels. The aim of this study was to evaluate the efficacy and safety of intravitreal injections of bevacizumab before trabeculectomy with mitomycin C (MMC) for the...

Full description

Bibliographic Details
Main Authors: Marjanović Ivan, Marjanović Marjan, Gvozdenović Ranko, Marjanović Marija, Marković Vujica, Božić Marija, Marić Vesna, Martinez Antonio
Format: Article
Language:English
Published: Military Health Department, Ministry of Defance, Serbia 2020-01-01
Series:Vojnosanitetski Pregled
Subjects:
diabetes mellitus
glaucoma, neovascular
bevacizumab
mitomycin
trabeculectomy
treatment outcome.
Online Access:http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800137M.pdf

Internet

http://www.doiserbia.nb.rs/img/doi/0042-8450/2020/0042-84501800137M.pdf

Similar Items